- O O O O
[Science O O O O
& O O O O
Research](/science-research) O O O O
- O O O O
[Science O O O O
News](/science-research/featured-science-news) O O O O
- O O O O
[Newsletter](/newsletter) O O O O
- O O O O
[2012](/newsletter/2012) O O O O
- O O O O
November O O O O
20 O O O O
Newsletter O O O O
Newsletter O O O O
Arthritis O O O O
Supplement O O O O
Use O O O O
Associated O O O O
With O O O O
Lower O O O O
Marker O O O O
Of O O O O
Inflammation O O O O
Arthritis Reason 5 O O
supplement Reason 5 O O
use Reason 5 O O
associated Reason 5 O O
with Reason 5 O O
lower Reason 5 O O
marker Reason 5 O O
of Reason 5 O O
inflammation Reason 5 O O
Tuesday, Reason 5 O O
November Reason 5 O O
20, Reason 5 O O
2012. Reason 5 O O
An Reason 5 O O
article Reason 5 O O
published Reason 5 O O
online Reason 5 O O
on Reason 5 O O
November Reason 5 O O
8, Reason 5 O O
2012 Reason 5 O O
in Reason 5 O O
the Reason 5 O O
Researchers Reason 5 O O
at Reason 5 O O
Seattle's Reason 5 O O
Fred Reason 5 O O
Hutchinson Reason 5 O O
Cancer Reason 5 O O
Center Reason 5 O O
analyzed Reason 5 O O
data Reason 5 O O
from Reason 5 O O
9,947 Reason 5 O O
men Reason 5 O O
and Reason 5 O O
women Reason 5 O O
who Reason 5 O O
participated Reason 5 O O
in Reason 5 O O
the Reason 5 O O
1999-2004 Reason 5 O O
cycles Reason 5 O O
of Reason 5 O O
the Reason 5 O O
National Reason 5 O O
Health Reason 5 O O
and Reason 5 O O
Nutrition Reason 5 O O
Examination Reason 5 O O
Survey Reason 5 O O
(NHANES). Reason 5 O O
Subject Reason 5 O O
interviews Reason 5 O O
provided Reason 5 O O
information Reason 5 O O
concerning Reason 5 O O
health Reason 5 O O
behaviors Reason 5 O O
and Reason 5 O O
diet, Reason 5 O O
including Reason 5 O O
the Reason 5 O O
type Reason 5 O O
and Reason 5 O O
frequency Reason 5 O O
of Reason 5 O O
dietary Reason 5 O O
supplements Reason 5 O O
used Reason 5 O O
during Reason 5 O O
the Reason 5 O O
prior Reason 5 O O
thirty Reason 5 O O
days. Reason 5 O O
Regular Reason 5 O O
use Reason 5 O O
of Reason 5 O O
a Reason 5 O O
supplement Reason 5 O O
was Reason 5 O O
defined Reason 5 O O
as Reason 5 O O
consumption Reason 5 O O
during Reason 5 O O
at Reason 5 O O
least Reason 5 O O
twenty Reason 5 O O
days Reason 5 O O
per Reason 5 O O
month. Reason 5 O O
Inflammation Reason 5 O O
was Reason 5 O O
assessed Reason 5 O O
via Reason 5 O O
blood Reason 5 O O
sample Reason 5 O O
analysis Reason 5 O O
for Reason 5 O O
serum Reason 5 O O
high Reason 5 O O
sensitivity Reason 5 O O
C-reactive Reason 5 O O
protein Reason 5 O O
(hs-CRP). Reason 5 O O
Higher Reason 5 O O
CRP Reason 5 O O
levels Reason 5 O O
were Reason 5 O O
observed Reason 5 O O
in Reason 5 O O
association Reason 5 O O
with Reason 5 O O
greater Reason 5 O O
age Reason 5 O O
and Reason 5 O O
body Reason 5 O O
mass Reason 5 O O
index. Reason 5 O O
Increased Reason 5 O O
dietary Reason 5 O O
fiber Reason 5 O O
was Reason 5 O O
associated Reason 5 O O
with Reason 5 O O
lower Reason 5 O O
CRP. Reason 5 O O
Participants Reason 5 O O
who Reason 5 O O
reported Reason 5 O O
regular Reason 5 O O
use Reason 5 O O
of Reason 5 O O
glucosamine Reason 5 O O
had Reason 5 O O
CRP Reason 5 O O
levels Reason 5 O O
that Reason 5 O O
were Reason 5 O O
17 Reason 5 O O
percent Reason 5 O O
less Reason 5 O O
on Reason 5 O O
average Reason 5 O O
in Reason 5 O O
comparison Reason 5 O O
with Reason 5 O O
those Reason 5 O O
who Reason 5 O O
didn't Reason 5 O O
use Reason 5 O O
glucosamine. Reason 5 O O
For Reason 5 O O
chondroitin Reason 5 O O
users, Reason 5 O O
the Reason 5 O O
reduction Reason 5 O O
in Reason 5 O O
CRP Reason 5 O O
averaged Reason 5 O O
22 Reason 5 O O
percent Reason 5 O O
and Reason 5 O O
for Reason 5 O O
fish Reason 5 O O
oil Reason 5 O O
users, Reason 5 O O
CRP Reason 5 O O
levels Reason 5 O O
averaged Reason 5 O O
16 Reason 5 O O
percent Reason 5 O O
lower. Reason 5 O O
When Reason 5 O O
supplement Reason 5 O O
use Reason 5 O O
was Reason 5 O O
analyzed Reason 5 O O
by Reason 5 O O
gender, Reason 5 O O
women Reason 5 O O
were Reason 5 O O
found Reason 5 O O
to Reason 5 O O
experience Reason 5 O O
greater Reason 5 O O
effects Reason 5 O O
from Reason 5 O O
glucosamine Reason 5 O O
and Reason 5 O O
chondroitin Reason 5 O O
in Reason 5 O O
comparison Reason 5 O O
with Reason 5 O O
men; Reason 5 O O
however, Reason 5 O O
men, Reason 5 O O
but Reason 5 O O
not Reason 5 O O
women, Reason 5 O O
experienced Reason 5 O O
a Reason 5 O O
reduction Reason 5 O O
in Reason 5 O O
CRP Reason 5 O O
in Reason 5 O O
association Reason 5 O O
with Reason 5 O O
the Reason 5 O O
use Reason 5 O O
of Reason 5 O O
ginseng. Reason 5 O O
The O O O O
authors O O O O
remark O O O O
that O O O O
fish O O O O
oil O O O O
contains O O O O
omega-3 O O O O
fatty O O O O
acids O O O O
that O O O O
reduce Reason 5 O O
inflammation Reason 5 O O
via Reason 5 O O
inhibition Reason 5 O O
of Reason 5 O O
nuclear Reason 5 O O
factor Reason 5 O O
kappa Reason 5 O O
beta Reason 5 O O
(NF-kB), Reason 5 O O
as Reason 5 O O
well Reason 5 O O
as Reason 5 O O
by Reason 5 O O
inhibition Reason 5 O O
of Reason 5 O O
proinflammatory Reason 5 O O
omega-6 Reason 5 O O
polyunsaturated Reason 5 O O
fatty Reason 5 O O
acids Reason 5 O O
by Reason 5 O O
displacement Reason 5 O O
of Reason 5 O O
omega-6 Reason 5 O O
stores Reason 5 O O
in Reason 5 O O
cell Reason 5 O O
membranes. Reason 5 O O
"To O O O O
our O O O O
knowledge, O O O O
this O O O O
is O O O O
the O O O O
largest O O O O
study O O O O
that O O O O
has O O O O
investigated O O O O
the O O O O
association O O O O
between O O O O
use O O O O
of O O O O
glucosamine O O O O
and O O O O
chondroitin O O O O
supplements O O O O
and O O O O
a O O O O
marker O O O O
of O O O O
inflammation O O O O
in O O O O
humans," O O O O
they O O O O
report. O O O O
"Our O O O O
finding O O O O
of O O O O
lower Reason 5 O O
hs-CRP Reason 5 O O
levels Reason 5 O O
among Reason 5 O O
users Reason 5 O O
of Reason 5 O O
glucosamine Reason 5 O O
and Reason 5 O O
chondroitin Reason 5 O O
supports Reason 5 O O
laboratory Reason 5 O O
studies Reason 5 O O
which Reason 5 O O
suggest Reason 5 O O
that Reason 5 O O
glucosamine Reason 5 O O
and Reason 5 O O
chondroitin Reason 5 O O
supplementation Reason 5 O O
may Reason 5 O O
reduce Reason 5 O O
inflammation Reason 5 O O
via Reason 5 O O
inhibition Reason 5 O O
of Reason 5 O O
nuclear Reason 5 O O
factor Reason 5 O O
kappa Reason 5 O O
B Reason 5 O O
activation." Reason 5 O O
"Given O O O O
the O O O O
number O O O O
of O O O O
diseases O O O O
with O O O O
which O O O O
inflammation O O O O
is O O O O
associated, O O O O
such O O O O
as O O O O
cancer O O O O
and O O O O
cardiovascular O O O O
disease, O O O O
there O O O O
is O O O O
a O O O O
need O O O O
to O O O O
find O O O O
safe O O O O
and O O O O
effective O O O O
ways O O O O
to O O O O
reduce O O O O
inflammation," O O O O
they O O O O
conclude. O O O O
"Research O O O O
suggests O O O O
that O O O O
these O O O O
three O O O O
supplements O O O O
have O O O O
excellent O O O O
safety O O O O
profiles, O O O O
supporting O O O O
their O O O O
potential O O O O
role O O O O
in O O O O
disease O O O O
prevention. O O O O
It O O O O
is O O O O
therefore O O O O
important O O O O
that O O O O
the O O O O
potential O O O O
antiinflammatory O O O O
role O O O O
of O O O O
these O O O O
supplements O O O O
be O O O O
further O O O O
investigated." O O O O
The O O O O
November, O O O O
2012 O O O O
issue O O O O
of O O O O
the O O O O
Professor O O O O
Nada O O O O
Alaaeddine, O O O O
who O O O O
is O O O O
the O O O O
Head O O O O
of O O O O
the O O O O
Regenerative O O O O
and O O O O
Inflammation O O O O
Lab O O O O
in O O O O
the O O O O
Faculty O O O O
of O O O O
Medicine O O O O
at O O O O
the O O O O
University O O O O
of O O O O
St O O O O
Joseph, O O O O
and O O O O
colleagues O O O O
assessed O O O O
the O O O O
use O O O O
of O O O O
alternative O O O O
and O O O O
complementary O O O O
therapies O O O O
among O O O O
250 O O O O
Lebanese O O O O
adults O O O O
aged O O O O
20 O O O O
to O O O O
90 O O O O
with O O O O
rheumatoid O O O O
or O O O O
osteoarthritis. O O O O
Questionnaires O O O O
completed O O O O
by O O O O
the O O O O
participants O O O O
provided O O O O
information O O O O
on O O O O
type O O O O
of O O O O
therapies O O O O
used O O O O
and O O O O
disease O O O O
status, O O O O
including O O O O
pain O O O O
intensity, O O O O
sleeping O O O O
pattern O O O O
and O O O O
activity O O O O
level, O O O O
before O O O O
and O O O O
after O O O O
treatment. O O O O
Fifty-eight O O O O
subjects O O O O
reported O O O O
the O O O O
use O O O O
of O O O O
complementary O O O O
or O O O O
alternative O O O O
arthritis O O O O
therapies O O O O
in O O O O
addition O O O O
to O O O O
conventional O O O O
medicine. O O O O
Those O O O O
who O O O O
used O O O O
complementary O O O O
therapies O O O O
tended O O O O
to O O O O
be O O O O
younger O O O O
than O O O O
nonusers, O O O O
and O O O O
were O O O O
likelier O O O O
to O O O O
have O O O O
osteoarthritis O O O O
than O O O O
rheumatoid O O O O
arthritis. O O O O
Therapies O O O O
reported O O O O
included O O O O
herbs, O O O O
exercise, O O O O
massage, O O O O
acupuncture, O O O O
meditation, O O O O
yoga O O O O
and O O O O
dietary O O O O
supplements. O O O O
Among O O O O
participants O O O O
who O O O O
reported O O O O
using O O O O
herbs, O O O O
the O O O O
majority O O O O
found O O O O
them O O O O
to O O O O
be O O O O
helpful. O O O O
Overall, O O O O
complementary Reason 5 O O
and Reason 5 O O
alternative Reason 5 O O
therapies Reason 5 O O
reduced Reason 5 O O
pain, Reason 5 O O
increased Reason 5 O O
sleep Reason 5 O O
and Reason 5 O O
improved Reason 5 O O
the Reason 5 O O
ability Reason 5 O O
to Reason 5 O O
engage Reason 5 O O
in Reason 5 O O
daily Reason 5 O O
activities. Reason 5 O O
Side O O O O
effects, O O O O
which O O O O
were O O O O
reported O O O O
in O O O O
a O O O O
minority O O O O
of O O O O
subjects, O O O O
were O O O O
not O O O O
considered O O O O
serious O O O O
and O O O O
were O O O O
reversible. O O O O
"Our O O O O
study O O O O
underlines O O O O
the O O O O
importance O O O O
of O O O O
healthcare O O O O
professionals O O O O
being O O O O
knowledgeable O O O O
about O O O O
the O O O O
potential O O O O
use O O O O
of O O O O
CAT O O O O
when O O O O
providing O O O O
medical O O O O
care O O O O
to O O O O
patients O O O O
with O O O O
arthritis" O O O O
Dr O O O O
Alaaeddine O O O O
commented. O O O O
"Complementary O O O O
and O O O O
alternative O O O O
therapy O O O O
use O O O O
is O O O O
increasing O O O O
and O O O O
this O O O O
study O O O O
shows O O O O
that O O O O
it O O O O
provided O O O O
self-reported O O O O
benefits O O O O
for O O O O
patients O O O O
with O O O O
